Aminothiazolones as estrogen related receptor-alpha modulators

Details for Australian Patent Application No. 2011218190 (hide)

Owner Janssen Pharmaceutica NV

Inventors Bignan, Gilles; Gaul, Micheal; Xu, Guozhang; Zhao, Bao-Ping

Agent Shelston IP

Pub. Number AU-A-2011218190

PCT Pub. Number WO2011/103134

Priority 61/305,181 17.02.10 US

Filing date 16 February 2011

Wipo publication date 25 August 2011

International Classifications

C07D 417/06 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 31/427 - not condensed and containing further heterocyclic rings

A61K 31/4439

A61P 19/00 Drugs for skeletal disorders

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

6 September 2012 PCT application entered the National Phase

  PCT publication WO2011/103134 Priority application(s): WO2011/103134

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011218194-Systems, methods, compositions and devices for in vivo magnetic resonance imaging of lungs using perfluorinated gas mixtures

2011218179-Method and device for non-invasive anatomical and systemic cooling and neuroprotection